STC1 and breast carcinoma: To determine the clinical significance of STC1 for breast cancer patients, we first measured the concentration of the STC1 protein in the serum of 60 breast cancer patients and 40 healthy women by ELISA, and the results showed that the concentration was higher in breast cancer patients than in healthy control women (Figure 6A).